Relapsed Diffuse Large B-Cell Lymphoma Treated by Reduced-Intensity Allogeneic Stem Cell Transplantation with Donor Lymphocyte Infusion

被引：0
|
作者：
Chaudhry, Qamar-un-Nisa [1 ]
Ahmed, Parvez [1 ]
Ullah, Khalil [1 ]
Satti, Tariq Mehmood [1 ]
Raza, Shahid
Mehmood, Syed Kamran
Akram, Mohammed
Ahmed, Suhaib [2 ]
机构：
[1] Armed Forces Bone Marrow Transplant Ctr, Dept Haematol, Near CMH, Rawalpindi, Pakistan
[2] Armed Forces Inst Pathol, Dept Haematol, Rawalpindi, Pakistan
来源：
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2010年 / 20卷 / 03期
关键词：
Relapsed non-Hodgkin's lymphoma; Reduced-intensity conditioning transplantation; Donor lymphocyte infusion; Diffuse B-cell lymphoma; NON-HODGKINS-LYMPHOMAS; ALEMTUZUMAB; DISEASE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 42 years old male with relapsed diffuse large B-cell lymphoma was given second-line chemotherapy followed by reduced intensity allogeneic stem cell transplantation from HLA matched brother. Twelve weeks posttransplant, his disease relapsed evidenced by the appearance of lymphoma cells in the peripheral blood and declining donor chimerism. Donor lymphocyte infusion was given that induced complete lymphoma remission. The patient is well 3 years posttransplant with his disease in complete remission.
引用
收藏
页码：211 / 213
页数：3
相关论文
共 50 条
  • [1] Donor lymphocyte infusion is an effective therapy for relapsed Hodgkin lymphoma after reduced-intensity allogeneic hematopoietic stem cell transplantation
    Utako oba
    Yuhki Koga
    Aiko Suminoe
    Toshiro Hara
    International Journal of Hematology, 2014, 100 : 511 - 513
  • [2] Donor lymphocyte infusion is an effective therapy for relapsed Hodgkin lymphoma after reduced-intensity allogeneic hematopoietic stem cell transplantation
    Oba, Utako
    Koga, Yuhki
    Suminoe, Aiko
    Hara, Toshiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (05) : 511 - 513
  • [3] Rituximab and donor lymphocyte infusions are an effective salvage treatment for B-cell lymphoma relapsing after reduced-intensity allogeneic stem cell transplantation
    Spina, F.
    Patriarca, F.
    Farina, L.
    Montefusco, V.
    Dodero, A.
    Carniti, C.
    Fanin, R.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S245 - S246
  • [4] Allogeneic stem cell transplantation with reduced-intensity conditioning in patients with relapsed lymphoma
    Rivas, M.
    Berro, M.
    Belaustegui, S.
    Prates, V.
    Yantorno, S.
    Milone, J.
    Remaggi, G.
    Rolon, J. Martinez
    Milone, G.
    Basquiera, A.
    Garcia, J.
    Sturich, G.
    Kusminsky, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S257 - S258
  • [5] Reduced-intensity allogeneic stem cell transplantation for diffuse large B-cell lymphoma: Clinical evidence of a graft-versus-lymphoma effect.
    Bishop, M. R.
    Dean, R. M.
    Steinberg, S.
    Odom, J.
    Pavletic, S. Z.
    Kasten-Sportes, C.
    Hardy, N.
    Pittaluga, S.
    Gress, R.
    Fowler, D. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 348S - 348S
  • [6] Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Devetten, Marcel P.
    Hari, Parameswaran N.
    Carreras, Jeanette
    Logan, Brent R.
    van Besien, Koen
    Bredeson, Christopher N.
    Freytes, Cesar O.
    Gale, Robert Peter
    Gibson, John
    Giralt, Sergio A.
    Goldstein, Steven C.
    Gupta, Vikas
    Marks, David I.
    Maziorz, Richard T.
    Vase, Julie M.
    Lazarus, Hillard M.
    Anderlini, Paolo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) : 109 - 117
  • [7] Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma
    Kato, Koji
    Sugio, Takeshi
    Ikeda, Takashi
    Yoshitsugu, Kanako
    Miyazaki, Kana
    Suzumiya, Junji
    Yamamoto, Go
    Kim, Sung-Won
    Ikegame, Kazuhiro
    Uehara, Yasufumi
    Mori, Yasuo
    Ishikawa, Jun
    Hiramoto, Nobuhiro
    Eto, Tetsuya
    Nakazawa, Hideyuki
    Kobayashi, Hikaru
    Serizawa, Kentaro
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Suzuki, Ritsuro
    BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 306 - 314
  • [8] Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma
    Koji Kato
    Takeshi Sugio
    Takashi Ikeda
    Kanako Yoshitsugu
    Kana Miyazaki
    Junji Suzumiya
    Go Yamamoto
    Sung-Won Kim
    Kazuhiro Ikegame
    Yasufumi Uehara
    Yasuo Mori
    Jun Ishikawa
    Nobuhiro Hiramoto
    Tetsuya Eto
    Hideyuki Nakazawa
    Hikaru Kobayashi
    Kentaro Serizawa
    Makoto Onizuka
    Takahiro Fukuda
    Yoshiko Atsuta
    Ritsuro Suzuki
    Bone Marrow Transplantation, 2024, 59 : 306 - 314
  • [9] Impact of donor lymphocyte infusion on outcome after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation
    Michallet, M
    Mohty, M
    Le, QH
    Michallet, AS
    Faucher, C
    Thiebaut, A
    Tavernier, E
    Raffi, H
    Revesz, D
    Troncy, J
    Praire, A
    Gadolet, E
    Raus, N
    Dubois, V
    Gebuhrer, L
    Hequet, O
    Bourgeot, JC
    Nicolini, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S204 - S205
  • [10] Allogeneic stem cell transplantation in MDS: reduced intensity conditioning and donor lymphocyte infusion
    Kroeger, N.
    LEUKEMIA RESEARCH, 2009, 33 : S28 - S28
12345